#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HER2 positive breast cancer

  • Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Epirubicin Hydrochloride
    • Olanzapine
    • Palonosetron Hydrochloride
    Belgium Norway Sweden

  • Study on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease

    Recruiting

    1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Pertuzumab
    • Trastuzumab
    • Trastuzumab Deruxtecan
    France

  • Zanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults

    Not yet recruiting

    1 1 1
    Investigated diseases:
    • Breast cancer
    • HER2 positive breast cancer
    Investigated drugs:
    • Hydrocortisone Sodium Succinate
    • Tucatinib
    • Zanidatamab
    Spain

  • Testing 68Ga-NOTA-ABSCINT-HER2 Imaging to Predict Treatment Response in Patients with HER2-Positive Early Breast Cancer Receiving Chemotherapy

    Not yet recruiting

    1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • 68Ga-Nota-Abscint-Her2
    France

  • A study of Zr89-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Trastuzumab
    • Trastuzumab Emtansine
    Belgium

  • Study of BB-1701 for Patients with HER2-positive or HER2-low Metastatic Breast Cancer

    Not recruiting

    1 1
    Investigated diseases:
    • Breast cancer metastatic
    • HER2 positive breast cancer
    Investigated drugs:
    • Humanised Igg1 Kappa Monoclonal Antibody Against Receptor Tyrosine-Protein Kinase Erbb-2 Conjugated To Eribulin
    France Germany Spain
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!